Complications of keratolimbal allograft surgery

Cornea. 2013 May;32(5):561-6. doi: 10.1097/ICO.0b013e31826215eb.

Abstract

Purpose: To report postoperative complications of keratolimbal allograft (KLAL) transplantation in patients with bilateral total limbal stem cell deficiency.

Methods: In this retrospective observational case series, medical charts of 45 patients with at least 6 months of follow-up were reviewed. The main outcome measure was postoperative complications including graft-related issues (thickness, position, and alignment) and immunologic rejection.

Results: Sixty-six KLALs were performed on 45 eyes. The mean follow-up period was 26.1 ± 11.8 months (range, 6-48 months). Primary failure occurred in 5 eyes primarily as a result of ocular surface exposure and severe dry eyes. Graft-related complications included misalignment (4 eyes), buttonhole (4), inner-edge tear (4), inadvertent limbal trephination (2), and thick KLAL (2). Postoperatively, regional thinning of the graft was observed in 8 KLALs as a result of exposure, regional ischemia, and after epithelial rejection. Acute rejection was diagnosed 16 times in 8 eyes, whereas chronic rejection was observed in 24 eyes. At last follow-up, 12 cases (26.6%) had failed because of recurrent acute rejection (4), chronic rejection (5), refractory herpetic keratitis (1), exposure (1), and refractory papillomavirus keratitis (1).

Conclusions: KLAL may be complicated by several adverse events. The most important complications are immunologic rejections, chronic ocular surface exposure, and graft-related complications.

MeSH terms

  • Adolescent
  • Adult
  • Cell Transplantation / methods*
  • Child
  • Corneal Diseases / pathology
  • Corneal Diseases / surgery*
  • Drug Therapy, Combination
  • Epithelium, Corneal / pathology
  • Epithelium, Corneal / transplantation*
  • Female
  • Graft Rejection / drug therapy
  • Graft Rejection / etiology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Limbus Corneae / pathology
  • Male
  • Middle Aged
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Postoperative Complications*
  • Retrospective Studies
  • Stem Cell Transplantation*
  • Tacrolimus / therapeutic use
  • Tissue Donors
  • Transplantation, Homologous
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Mycophenolic Acid
  • Tacrolimus